Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders - Scorecard - MDSpire

Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders

  • By

  • Yating Li

  • Silvia Turroni

  • Lan Gong

  • Ding Shi

  • April 28, 2026

  • 0 min

Share

Clinical Scorecard: Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationExpand to include all conditions discussed in the source.
Care Setting

Key Highlights

  • Akkermansia muciniphila

Guideline-Based Recommendations

Diagnosis

    Management

    • acupuncture

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with dysbiosis-related conditions such as IBD and IBS

        Targeted interventions using microbial metabolites and natural polysaccharides may improve outcomes

        Clinical Best Practices

        • precision medicine

        References

        Original Source(s)

        Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders

        • by Yating Li, Silvia Turroni, Lan Gong, Ding Shi

        • April 28, 2026

        Related Content

        The innovation trap: How pharma weaponizes a word to extend monopolies

        Curbing Drug-Related Halitosis for Closer Moments

        Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

        Progression of Coronary Calcium Detected on Routine Chest CT Enhances Cardiovascular Risk Assessment in Individuals with Inflammatory Bowel Disease: Findings from a Multicenter Study